- Home
- LCFY vs EDSA Comparison
LCFY vs EDSA Comparison
Compare LCFY & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- EDSA
- Stock Information
- Founded
- LCFY 2009
- EDSA 2015
- Country
- LCFY Australia
- EDSA Canada
- Employees
- LCFY N/A
- EDSA N/A
- Industry
- LCFY
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- EDSA Health Care
- Exchange
- LCFY Nasdaq
- EDSA Nasdaq
- Market Cap
- LCFY 5.8M
- EDSA 6.2M
- IPO Year
- LCFY 2022
- EDSA N/A
- Fundamental
- Price
- LCFY $3.98
- EDSA $1.83
- Analyst Decision
- LCFY
- EDSA Strong Buy
- Analyst Count
- LCFY 0
- EDSA 1
- Target Price
- LCFY N/A
- EDSA $21.00
- AVG Volume (30 Days)
- LCFY 12.9K
- EDSA 36.4K
- Earning Date
- LCFY 06-17-2025
- EDSA 05-14-2025
- Dividend Yield
- LCFY N/A
- EDSA N/A
- EPS Growth
- LCFY N/A
- EDSA N/A
- EPS
- LCFY N/A
- EDSA N/A
- Revenue
- LCFY $2,668,385.00
- EDSA N/A
- Revenue This Year
- LCFY N/A
- EDSA N/A
- Revenue Next Year
- LCFY N/A
- EDSA N/A
- P/E Ratio
- LCFY N/A
- EDSA N/A
- Revenue Growth
- LCFY N/A
- EDSA N/A
- 52 Week Low
- LCFY $2.20
- EDSA $1.55
- 52 Week High
- LCFY $11.23
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- LCFY 43.83
- EDSA 29.28
- Support Level
- LCFY $3.86
- EDSA $1.88
- Resistance Level
- LCFY $4.30
- EDSA $2.05
- Average True Range (ATR)
- LCFY 0.21
- EDSA 0.08
- MACD
- LCFY -0.02
- EDSA -0.00
- Stochastic Oscillator
- LCFY 19.78
- EDSA 0.00
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.